
AEZS
Healthcare · Biotechnology · $17.5M market cap
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Mar 31, 2024
EPS trend, 90 days to now · +100.0% over 90 days · 30-day revisions 0 up, 0 down
Beat estimates in 1 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| May 14, 2024 | After the close | -0.81 | -18.95 | -2239.8% |
| Mar 27, 2024 | Before the open | -0.97 | -1.16 | -19.6% |
| Nov 9, 2023 | Before the open | -0.61 | -0.85 | -39.3% |
| Aug 9, 2023 | Before the open | -0.87 | -0.52 | +40.2% |
| May 9, 2023 | After the close | -1.07 | -0.88 | +17.8% |
| Mar 23, 2023 | Before the open | -0.93 | -0.87 | +6.5% |
| Nov 3, 2022 | Before the open | -0.68 | -0.70 | -2.9% |
| Aug 3, 2022 | After the close | -0.68 | -0.87 | -27.9% |
| May 9, 2022 | After the close | -0.50 | -0.50 | 0.0% |
| Mar 27, 2022 | After the close | -0.50 | -0.50 | 0.0% |
| Nov 4, 2021 | After the close | -0.50 | -0.25 | +50.0% |
| Aug 5, 2021 | Before the open | -0.17 | -0.02 | +88.2% |
| May 5, 2021 | Before the open | — | -0.02 |
Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests in Canada, Switzerland, Ireland, Denmark, Germany, the United States, and internationally. Its lead product is Macrilen (macimorelin), an orally available peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a…
| — |
| Mar 25, 2021 | Before the open | -0.11 | -0.05 | +54.5% |
| Nov 6, 2020 | Before the open | -0.11 | -0.02 | +81.8% |
| Aug 8, 2020 | Before the open | -0.11 | -0.15 | -36.4% |
| May 6, 2020 | After the close | 1.68 | 0.04 | -97.6% |
| Mar 30, 2020 | Before the open | -0.12 | -0.05 | +58.3% |
| Nov 7, 2019 | After the close | -4.25 | -0.50 | +88.2% |
| Aug 13, 2019 | After the close | -3.50 | 0.25 | +107.1% |
| May 7, 2019 | After the close | 1.00 | -6.75 | -775.0% |
| Mar 26, 2019 | After the close | -4.75 | -7.75 | -63.2% |
| Nov 6, 2018 | After the close | -6.25 | -3.75 | +40.0% |
| Aug 9, 2018 | After the close | -8.00 | -4.00 | +50.0% |
| May 7, 2018 | After the close | 14.63 | 21.75 | +48.7% |
| Mar 28, 2018 | Before the open | -7.75 | -6.00 | +22.6% |